10 Feb 2025 / News, Research

New Approach to Treat Patients with Checkpoint Inhibitor-induced Adverse Events (Apostolova Lab)

Immune checkpoint inhibitors (ICI), such as anti-PD-1 and anti-CTLA4 antibodies, enhance anti-cancer immunity and are a potent treatment for several types of cancer. However, overt activation of the immune system can also cause severe…

08 Feb 2025 / News, Research

New Findings on Immune Dysfunction and Lymphoma Risk (Binder Lab)

Lymphocytes are essential for health, but when they malfunction, they can cause immune deficiencies, autoimmune diseases, or cancer. Autoimmune disorders and certain blood cancers, such as non-Hodgkin’s lymphoma, share similar disease…

30 Jan 2025

Department of Biomedicine Newsletter No. 9

We are pleased to announce the release of the ninth edition of our DBM Newsletter. We hope you enjoy reading it!

28 Jan 2025 / News, Research

Exploring the Impact of Drugs on Cellular Metabolism (Zampieri Lab)

Researchers in Mattia Zampieri's Systems Pharmacology and Biology of Metabolism lab have developed a novel method to study how thousands of active compounds simultaneously affect cellular metabolism. This approach offers new insights into…

21 Jan 2025 / News, People

Two SNSF Advanced Grants for the Department of Biomedicine

Cancer researcher Prof. Dr. Mohamed Bentires-Alj and diabetes researcher Prof. Dr. Marc Donath have each been awarded one of the highly competitive grants from the Swiss National Science Foundation (SNSF). Both projects address socially…